This example contains ECG measurements during a repeat dose study. Results are for a discrete observation period with a target time point (e.g., 1 hour post-dose). The duration of the ECG recording could be based on a defined period of time (e.g., a cardiologist examining a 2-hour recording and selecting a segment of waveforms for analysis) or number of complexes (e.g., after 200 good complexes are recorded). As a result, EGSTINT and EGENINT are not populated, because the specific assessment interval is not planned.
eg.xpt
Rows 1-18: ECGs are performed once, 14 days prior to the day 1 dose; and twice on day 23, once immediately prior to dose and once 2 hours post-dose. Measurements that were collected originally in seconds are converted to units of milliseconds for the study.
eg.xpt
eg.xpt
1 TSA1397 EG 1 1 EGHRMN ECG Mean Heart Rate SLING 89 beats/min 89 89 beats/min LEAD II 6 LEAD STANDARD CONSCIOUS 2008-10-28T07:46 -14 -14 Pretest 1 -P14D Day 1 Dose 2008-11-11T08:54 2 TSA1397 EG 1 2 EGHRMN ECG Mean Heart Rate SLING 91 beats/min 91 91 beats/min LEAD II 6 LEAD STANDARD CONSCIOUS Y 2008-12-03T09:05 23 23 Predose 2 -PT5M Day 23 Dose 2008-12-03T09:10 3 TSA1397 EG 1 3 EGHRMN ECG Mean Heart Rate SLING 116 beats/min 116 116 beats/min LEAD II 6 LEAD STANDARD CONSCIOUS 2008-12-03T11:03 23 23 2 Hour Postdose 3 PT120M Day 23 Dose 2008-12-03T09:10 4 TSA1397 EG 1 4 QRSAG QRS Duration, Aggregate SLING 0.050 sec 50 50 msec LEAD II 6 LEAD STANDARD CONSCIOUS 2008-10-28T07:46 -14 -14 Pretest 1 -P14D Day 1 Dose 2008-11-11T08:54 5 TSA1397 EG 1 5 QRSAG QRS Duration, Aggregate SLING 0.038 sec 38 38 msec LEAD II 6 LEAD STANDARD CONSCIOUS Y 2008-12-03T09:05 23 23 Predose 2 -PT5M Day 23 Dose 2008-12-03T09:10 6 TSA1397 EG 1 6 QRSAG QRS Duration, Aggregate SLING 0.039 sec 39 39 msec LEAD II 6 LEAD STANDARD CONSCIOUS 2008-12-03T11:03 23 23 2 Hour Postdose 3 PT120M Day 23 Dose 2008-12-03T09:10 7 TSA1397 EG 1 7 PPAG PP Interval, Aggregate SLING 0.073 sec 73 73 msec LEAD II 6 LEAD STANDARD CONSCIOUS 2008-10-28T07:46 -14 -14 Pretest 1 -P14D Day 1 Dose 2008-11-11T08:54 8 TSA1397 EG 1 8 PPAG PP Interval, Aggregate SLING 0.083 sec 83 83 msec LEAD II 6 LEAD STANDARD CONSCIOUS Y 2008-12-03T09:05 23 23 Predose 2 -PT5M Day 23 Dose 2008-12-03T09:10 9 TSA1397 EG 1 9 PPAG PP Interval, Aggregate SLING 0.076 sec 76 76 msec LEAD II 6 LEAD STANDARD CONSCIOUS 2008-12-03T11:03 23 23 2 Hour Postdose 3 PT120M Day 23 Dose 2008-12-03T09:10 10 TSA1397 EG 1 10 QTAG QT Interval, Aggregate SLING 0.209 sec 209 209 msec LEAD II 6 LEAD STANDARD CONSCIOUS 2008-10-28T07:46 -14 -14 Pretest 1 -P14D Day 1 Dose 2008-11-11T08:54 11 TSA1397 EG 1 11 QTAG QT Interval, Aggregate SLING 0.222 sec 222 222 msec LEAD II 6 LEAD STANDARD CONSCIOUS Y 2008-12-03T09:05 23 23 Predose 2 -PT5M Day 23 Dose 2008-12-03T09:10 12 TSA1397 EG 1 12 QTAG QT Interval, Aggregate SLING 0.192 sec 192 192 msec LEAD II 6 LEAD STANDARD CONSCIOUS 2008-12-03T11:03 23 23 2 Hour Postdose 3 PT120M Day 23 Dose 2008-12-03T09:10 13 TSA1397 EG 1 13 QTCFAG QTcF Interval, Aggregate SLING 0.238 sec 238 238 msec LEAD II 6 LEAD STANDARD CONSCIOUS 2008-10-28T07:46 -14 -14 Pretest 1 -P14D Day 1 Dose 2008-11-11T08:54 14 TSA1397 EG 1 14 QTAG QT Interval, Aggregate SLING 0.255 sec 255 255 msec LEAD II 6 LEAD STANDARD CONSCIOUS Y 2008-12-03T09:05 23 23 Predose 2 -PT5M Day 23 Dose 2008-12-03T09:10 15 TSA1397 EG 1 15 QTAG QT Interval, Aggregate SLING 0.240 sec 240 240 msec LEAD II 6 LEAD STANDARD CONSCIOUS 2008-12-03T11:03 23 23 2 Hour Postdose 3 PT120M Day 23 Dose 2008-12-03T09:10 16 TSA1397 EG 1 16 QTCVAG QTcV Interval, Aggregate SLING 0.237 sec 237 237 msec LEAD II 6 LEAD STANDARD CONSCIOUS 2008-10-28T07:46 -14 -14 Pretest 1 -P14D Day 1 Dose 2008-11-11T08:54 17 TSA1397 EG 1 17 QTCVAG QTcV Interval, Aggregate SLING 0.252 sec 252 252 msec LEAD II 6 LEAD STANDARD CONSCIOUS Y 2008-12-03T09:05 23 23 Predose 2 -PT5M Day 23 Dose 2008-12-03T09:10 18 TSA1397 EG 1 18 QTCVAG QTcV Interval, Aggregate SLING 0.234 sec 234 234 msec LEAD II 6 LEAD STANDARD CONSCIOUS 2008-12-03T11:03 23 23 2 Hour Postdose 3 PT120M Day 23 Dose 2008-12-03T09:10
$warningHtml